Orthocell (ASX:OCC) has appointed its first four US distributors operating in Michigan, Virginia, Colorado, and Indiana, for its nerve repair device Remplir, according to a Wednesday filing with the Australian bourse.
Manufacturing and logistics are in place, with significant inventory ready to support initial sales, the filing said.
Shares of the company rose 6% in recent Wednesday trade.